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Abstract 
Diabetes mellitus (DM) is a metabolic disease, and its prevalence has increased over the              
last decades, affecting more than 8.6% of the world population. Despite extensive            
research, ​the mechanism of diabetes development and its complications are still not fully             
understood. ​The present review was designed to describe ​in vitro methods used to study              
diabetes mellitus, with a critical analysis of their advantages and limitations. We searched             
Pubmed database for free full-text articles that were published between 2014 and 2019             
that contained “​diabetes mellitus​” and “​in vitro​” in their content and restricted the result to               
human studies using the species filter. Clinical reports were excluded. ​The search and             
filtering of articles rendered 927 results, of which 25 were used in this review. The majority                
of studies used glucose modulation models, even though primary cells and serum derived             
from DM patients were also used, in addition to varied strategies focused on mimicking              
isolated aspects of the disease. ​Therefore, different model systems are available for the             
study of diabetes mellitus ​in vitro​, each with its own set of advantages and limitations. The                
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present review will provide relevant information, which may support the appropriate choice            
of experimental models in the field. 
 





















1.  Introduction  
The term Diabetes mellitus (DM) describes a group of metabolic disorders           
characterized by high blood glucose levels. People with diabetes have an increased risk of              
developing a number of serious life-threatening health problems resulting in higher           
medical care costs, reduced quality of life, and increased mortality. The global prevalence             
of diabetes is increasing over the last decades. It was estimated that in 2017, there were                
451 million people (age 18–99 years) with diabetes worldwide, and these figures are             
expected to increase to 693 million by 2045 ​[1]​. Despite the different etiology of type 1 and                 
type 2 diabetes, no separate global epidemiological data exists ​[2]​. The mechanisms by             
which elevated glucose levels lead to tissue damage are multifaceted, and nowadays, DM             
is the leading cause of end-stage renal disease and blindness in Europe and North              
America. Moreover, it increases the risk of microangiopathies and the development of            
cataracts, erectile dysfunction, and cognitive impairment, like Alzheimer’s disease ​[3]​. 
Type 1 diabetes (T1DM), which is an insulin-dependent type of diabetes, is a              
chronic disease affecting genetically predisposed individuals, in which insulin-secreting         
beta (β)-cells within pancreatic islets of Langerhans are selectively and irreversibly           
destroyed by autoimmune assault. Type 2 diabetes (T2DM) is characterized by a gradual             
decrease in insulin sensitivity in peripheral tissues and the liver (insulin resistance),            
followed by a gradual decline in β-cell function and insulin secretion. Despite their             
differences, both T1DM and T2DM patients suffer from inadequate amounts of insulin            
production in order to maintain normoglycemia ​[4]​. 
The present article aims to provide both an overview of the most relevant in vitro                
models currently in use for diabetes research and a critical analysis of each in regards to                
its advantages and limitations. The following topics are considered: general discussion of            
in vitro and ​in vivo ​experimental models for DM research, glucose modulation strategies,             
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primary cell cultures derived from DM patients, cell culture with DM patients’ serum, and              
strategies focused on isolated aspects of the disease, as shown in table 1 and 2. 
 
2.  Materials and methods 
We searched Pubmed database for free full-text articles that were published           
between September 1st, 2014, and September 1st, 2019, that contained “diabetes           
mellitus” and “​in vitro​” in their content and restricted the result to human studies using the                
species filter. Clinical reports were excluded. After the filtering, the search rendered 927             
papers, of which 25 were used in this review, as seen in table 1. A summary of the models                   
used and their advantages and limitations are shown in table 2. 
 
3. Results and discussion 
3.1. ​In vitro ​and ​in vivo ​experimental models for DM research: general            
discussion 
DM is a severe and chronic disease associated with complex comorbidities and            
high economic impact. Therefore, the search for a better understanding of the disease             
pathophysiology is currently an unmet need to discover, validate, and optimize preventive            
and therapeutic strategies. In order to study the diverse DM aspects, different tools and              
experimental settings are available, all of which present advantages and limitations.           
Therefore, for each scientific question, it is crucial to analyze and carefully select the most               
adequate experimental model. For instance, while ​in vivo studies provide physiological           
details of DM and associated comorbidities, the complexity of the system generates many             
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variables that are hard to account for and can compromise data analysis. Furthermore, as              
revised by Kleinert ​et al​., non-mammalian models of DM may be attractive alternatives for              
DM research, due to their low cost and short life cycle, but are limited due to their distinct                  
genetic and physiology. Rodents, on the other hand, are extensively used for research in              
several fields, due to the apparent familiarity of researchers with those cost-effective            
models, and the possibility of genetically modifying them, but in the context of DM              
research, such animals lack genetic diversity and differ in their pancreas architecture from             
that of humans ​[5]​. 
Considering the complex etiology of DM and the frequent presence of           
comorbidities in patients, the possibility of isolating variables is a relevant aspect of ​in vitro               
experimental models, as condition control is more straightforward in those models. 
RNA interference, transcriptional gene silencing, virus-induced gene silencing,        
microRNAs, and, more recently, CRISPR and base editors technology comprise a series            
of mechanisms capable of controlling gene activity and cellular phenotypes. This ability to             
modify and even knockout targeted genes is a valuable tool to assess and confirm              
hypotheses regarding molecule functions within the cell ​[6]​. 
For instance, F. Yang ​et al​. have investigated diabetic cardiomyopathy (DCM),           
which is a common complication of DM and has recently been associated with pyroptosis              
events — a type of programmed cell death related to inflammation. In order to clarify the                
molecular mechanism behind such a process, and also taking into consideration that the             
long non-coding RNA (lncRNA) Kcnq1ot1 participates in many cardiovascular diseases,          
human cardiomyocyte cells (AC16) and primary cardiomyocytes were cultured in vitro with            
5.5 and 50 mmol/L glucose. It was found that the expression of Kcnq1ot1 was increased in                
cardiomyocytes cultured in hyperglycemic conditions, which was in accordance with          
readings taken from patients with diabetes and diabetes-induced mouse cardiac tissue.           
The authors have also shown that silencing Kcnq1ot1 inhibits pyroptosis by influencing            
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miR-214-3p and caspase-1 expression, which reduced cell death ​in vitro​ and ​in vivo​ ​[7]​.  
In vitro models are also convenient to measure kinetics, as changes in pH and              
colorimetric assays, for example, can be used to monitor cell response to changes in the               
environment and progression of treatments. An ​in vitro protocol was developed by Varberg             
et al​, using fetal endothelial colony forming cells (ECFCs) exposed to maternal DM plated              
in slides containing basement membrane matrix and a microscope set to acquire shots             
every 15 minutes so as to stack the images and assess the kinetics of ​in vitro                
vasculogenesis in order to quantitate rates of network formation and stabilization ​[8]​. 
The ethical concern of society also renders the search for methods to replace,             
refine, and reduce animal use, which is a paramount concern for researchers. First             
promulgated in 1959, the 3Rs — Replacement, Reduction, and Refinement — have            
evolved as fundamental principles underlying the use of animals and alternatives in            
science throughout the modern world ​[9]​. As technology advanced and new           
methodologies were developed, the number of studies that required regulated animal           
procedures decreased considerably in the last decades, and that is mainly thanks to ​in              
vitro​ culture studies ​[10–12]​. 
Some limitations need to be considered when working ​in vitro rather than ​in vivo​.              
For example, certain cell lines, like neurons and pluripotent stem cells, are difficult to              
culture, as some require particular media and environmental conditions that are hard to             
establish and maintain ​[13]​. Furthermore, cellular behavior can be influenced by even            
small variations in environmental factors such as temperature, CO​2 levels, pressure, and            
culture confluency ​[14,15]​. 
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3.2. Strategies for modeling DM ​in vitro  
3.2.1. Glucose modulation strategies 
Modulation of levels of glucose in the culture media was the most frequently used              
method to mimic diabetic conditions ​in vitro seen in the papers used in this review, as                
shown in table 1. This is an easy and cheap alternative to emulate the major variable that                 
is associated with the disease. Most basic cell culture media contain 5.5mM of glucose,              
which is the equivalent of a healthy person’s blood sugar level of 99mg/dL ​[16]​. Most               
studies supplement media with glucose as to mimic hyperglycemia reaching          
concentrations ranging from as low as 7mM to 50mM, although most are found to use               
~30mM as a hyperglycemic “diabetic status.” 
It is a great alternative to study the cellular response to high-glucose environment,             
even though it doesn’t mirror chronic effects of the disease, as in this case, it begins to                 
involve other physiological variables, such as hormone imbalances and inflammatory          
responses observed in patients that have lived with diabetes for an extended period of              
time. Nevertheless, there are some limitations to the strategy of glucose modulation that             
needs to be addressed. For example, the exposure of cells to high glucose fails to mimic                
in vivo heterogeneous conditions where cells are exposed to variable glucose levels that             
fluctuate gradually through time. ​In vitro​, these changes occur abruptly each time the             
culture media is replaced, which raises the possibility that the cell response to the glucose               
may not be only because of its high level per se, but due to osmotic stress. Ueck ​et al​.                   
found that when using hyperglycemic keratinocytes in scratch wound assays to mimic            
diabetic wound healing, the hyperosmolar aspect of hyperglycemia played a significant           
role in compromising keratinocyte migration, since the same effect was observed in            
hyperosmolar conditions ​[17]​. In this sense, the addition of mannitol or fructose in             
experimental controls may be necessary ​[18]​.  
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Microfluidic systems constitute an attractive alternative in this scenario. Such          
systems allow for better reproduction of the glycemic fluctuations seen ​in vivo​, which can              
also be designed to mimic and emulate human biology in order to study more complex               
physiological systems interactions. Bauer ​et al​. developed a human microfluidic          
two-organ-chip model to study pancreatic islet–liver cross-talk based on insulin and           
glucose regulation, managing to obtain a functional feedback loop between human           
pancreatic islet microtissues and liver spheroids that can provide an ​in vitro system able to               
emulate T2DM ​[19]​. Finally and also of note, regardless of the cell culture system, the               
presence of metals, such as iron in media and calf serum — commonly used as a                
supplement in cell culture — may exacerbate the effects of high glucose and must be               
considered when drawing conclusions from each experiment ​[15]​. 
 
3.2.2. Primary cell cultures derived from DM patients  
Primary cell cultures obtained from patients with diabetes constitute another          
methodology to study the disease ​in vitro​. One great advantage of this method is that the                
system allows, to a certain extent, to “import” the chronic physiological conditions from the              
patient into cell culture. This strategy enables the study of the impact of a high-glucose               
environment on the tissue over a long period. Such temporal “snapshot,” however, needs             
to be taken into account during results analysis, as some of the conclusions may not apply                
to younger or older cells, or even to the same cell type harvested from another location or                 
patient, since ​in vivo​ conditions are highly dynamic ​[14]​. 
As tissue samples can be obtained and cultured, studies on cellular interaction can             
be performed ​in vitro​. The development of 3D co-cultures that resemble ​in vivo physiology,              
as well as organotypic cultures, were a great advance and an especially useful tool to               
study several tissues in the context of DM, such as the ​corneal nerve dysfunction,              
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frequently seen in DM patients. The lack of human ​in vitro models that can successfully               
mimic the complexity of corneal tissue ​in vivo​, which is organized in distinct layers devoid               
of blood vessels, results in very few studies involving the interactions between the corneal              
stroma and the stromal nerves. The improvement of ​in vitro models based on co-cultures              
also enables researchers in the field to develop studies on ​corneal degeneration ​[20–22]​. 
In addition, this methodology is useful to investigate the inflammatory and           
immunological responses, which are usually dysfunctional in DM patients. In ​type 1            
diabetes patients, the immune system is primarily involved in beta cell destruction​, and in              
type 2 patients, the systemic inflammation is also a hallmark of the disease ​[23,24]​. Due to                
organ dysfunction and the inflammatory nature of DM, recent studies aim to explore             
regenerative medicine alternatives to tackle the disease. In this scenario, the therapeutic            
potential of mesenchymal stem cells (MSC) on tissue regeneration and insulin resistance            
stands out as they appear to modulate immune response effectively  [25,26]. 
Importantly, some limitations are observed in primary culture-based DM studies.          
Primary cells require ethical approval to be assessed, and - for some cell types - may only                 
be obtained from invasive procedures, limiting their availability. After obtention, cellular           
contaminants, such as microbiological contaminants and undesired cell types may also           
alter cell culture quality. For instance, some cell lines are difficult to harvest and isolate,               
rendering them difficult to work with, since after some time in culture, those contaminant              
cells may be expanded and compromise the experiment. Glial and Schwann cells are an              
example of such cell lines, as they are difficult to isolate from fresh nerves, due to an                 
abundance of connective tissue and other myelinating cells in the tissue ​[14,21]​.            
Moreover, cells undergo alteration in some of their properties after culture and successive             
passages, ceasing to divide and eventually progressing to senescence and death. This            
limits experiments that require a large number of cells or that are intended to involve long                
periods of observation ​[27]​. 
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It is also worth mentioning the use of differentiated stem cells in research. Some              
studies are being conducted using induced pluripotent stem cells (iPSCs)-derived cells           
rather than primary cultures. This methodology holds much promise as research is being             
done in order to generate stem cell-derived β-cells from patients with type 1 diabetes, as               
transplantation of exogenous β-cells to replace dead or dysfunctional endogenous β-cells           
is a potential strategy for controlling blood glucose levels in those patients ​[28–30]​. 
 
3.2.3.Cell culture with DM patients’ serum 
A recent developing area of study in diabetes research is the role of diabetic serum               
in the pathology of the disease. Studies involving the control of glucose concentration, for              
example, indicate that the anti-angiogenic properties of T2DM serum are independent of            
hyperglycemia levels. Thus, it appears that T2DM results in imbalances in other circulating             
factors, such as growth factors and cytokines, which may have additional impact on             
endothelial cell behavior and help explain the altered vascular endothelial function           
observed in DM patients. A study published in 2019 demonstrated that circulating factors             
present in the serum of T2DM individuals impaired in vitro endothelial cell capillary-like             
network formation in both primary and telomerized endothelial cell lines. The research            
suggested that elevation in interleukin-6 and its soluble receptor may be responsible for             
such alterations and may play a role in the mechanism underlying vascular impairments             
and reduced angiogenesis often found in T2DM ​[31]​. 
Also, in recent years, the role of extracellular vesicles (EVs) in T2DM have             
attracted much attention. EVs are bilayer membrane vesicles secreted from most cells and             
can participate in regulating various physiological and pathological processes in vivo by            
being transported between cells. Recently, it was discovered that some abnormal EVs can             
contribute to the occurrence of T2DM by inducing insulin resistance and can also             
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participate in the complications of the disease ​[32]​. They also appear to play a role in                
amyloid formation seen in patients with diabetes ​[33]​.  
Findings like these introduce a new way to study diabetes ​in vitro as researchers              
can simulate the effects of the disease culturing healthy cells in culture media             
supplemented with serum harvested from diabetes patients. It is important to point out that              
the difficulty of assessing the exact content of the harvested serum and EVs must be               
taken into account when using this methodology, as mentioned by the International            
Society of Extracellular Vesicles (ISEV) ​[34]​. 
 
3.2.4. Strategies focused on isolated aspects of the disease 
Even though the use of primary cells and serum/plasma obtained from DM patients             
allows for the isolation of some aspects of DM, such strategies still bring a snapshot of                
various biological alterations that can be observed in the isolated cells and serum. When              
going through all the experimental approaches of the manuscripts published in the last few              
years, another possibility of modeling DM in a dish was observed: the isolation and              
experimentation of one or few specific factors without using a hyperglycemic environment            
or primary cells harvested from patients with diabetes. That way, the impact of a single               
factor can be measured and correlated with the clinical aspects of the disease. 
Such methodology was used in a study performed to assess the relationship            
between Parkinson’s disease (PD) and T2D in an experiment using only amyloid            
precursors. In T2D and PD, polypeptide assembly into amyloid fibers plays central roles.             
In PD, α-synuclein (aS) forms amyloids, and in T2D, amylin (islet amyloid polypeptide -              
IAPP) forms amyloids. The authors then assessed the cross-reactivity between these           
amyloid precursors revealing a simple justification as to why T2D is a risk factor for PD,                
whereas patients with PD are not prone to developing T2D ​[35]​. 
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4. Conclusion and perspectives 
The selection of the appropriate experimental approach to apply within a study is             
an important step in experimental design, and the strengths and weaknesses of each             
experimental tool must be weighed upon decision. There is a broad variety of             
experimental systems available for the study of diabetes. ​In vitro models are useful to              
study individual aspects of the disease as they enable the researcher to assess the              
intricate interaction of cells and surrounding factors. They are also useful to provide initial              
exploratory data, since they are usually far cheaper and easier models to work with, when               
compared to ​in vivo​ models.  
It is also important to bear in mind that results obtained via ​in vitro experiments               
require further confirmation with ​in vivo studies, as to support the occurrence of similar              
outcomes in the presence of other interferent factors, and thus help to enlighten the              
underlying mechanisms of the disease towards the ​discovery, validation and optimization           
of preventive and therapeutic strategies for DM. Moreover, as a careful reading of the              
articles cited in table 1 shows, most published studies do not rely on only a single ​in vitro                  
model, as most of the time different experimental approaches are needed to test and              
support a hypothesis. 
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Appendix 
Table 1. In vitro models used for studies on diabetes mellitus 





Topical administration of bosentan prevents retinal 
neurodegeneration induced by hyperglycemia and tumor 
necrosis factor α 
[20] 
High glucose induce interleukin-1β and soluble interleukin-6 
receptor production from macrophages in inflammatory 
periodontal tissue 
[36] 
Silencing KCNQ1 overlapping transcript 1 inhibits pyroptosis 
and is overexpressed in diabetic cardiomyopathy model 
[7] 
Choline and betaine modified some, but not all, determinants 
of placental transport in response to hyperglycemia 
[18] 
Bellis perenis​ (common daisy) induced insulin-like effect in 
glucose transporter 4 translocation 
[37] 
Diphlorethohydroxycarmalol Isolated from 
Ishige okamurae represses high glucose-induced 
angiogenesis 
[38] 
Heat shock protein 22 suppresses diabetes-induced 
endothelial injury by inhibiting 
mitochondrial reactive oxygen species formation 
[39] 
Chrysin, present in bee propolis and herbs, inhibits advanced 
glycation end products-induced kidney fibrosis and 
glomerulosclerosis  
[40] 
Tissue factor and toll like receptor 4 plays a significant role in 
high glucose-induced mitochondrial dysfunction, 
mitochondria-related oxidation, and apoptosis by regulating 
[41] 
24 
downstream protein peroxisome proliferator-activated receptor 
γ coactivator-1α in renal tubular epithelial cells 
High glucose suppresses the viability and proliferation of 
trophoblast cells through microRNA-137, protein kinase 
AMP-activated catalytic subunit α1 and interleukin-6 axis 
[42] 
Angiotensin II aggravates lipopolysaccharide induced 
human pulmonary microvascular endothelial cell permeability 
in high glucose status 
[43] 
Hyperglycemia increase cellular reducing equivalents but 
reduce survival of 661W photoreceptor-like cell injury 
[22] 
Peroxisome proliferator-activated receptor β/δ activation 
confers vascular protection against hyperglycemia-induced 
oxidative stress 
[44] 
High glucose increases tissue factor and toll like receptor 4 
and tissue factor-procoagulant activity in healthy subjects 
[16] 
Triterpene extract is a promising candidate to ​in vivo​ testing in 
diabetic wounds and environmental influences like 
hyperosmolarity are important in wound healing assay 
[17] 
Development of a novel human T2DM ​in vitro​ model based on 
a microfluidic two-organ-chip model to study pancreatic 
islet–liver cross-talk based on insulin and glucose regulation 
[19] 
 Primary cell 
cultures derived 
from DM patients  
1,25-dihydroxyvitamin-D3 promotes neutrophil apoptosis 




MicroRNA-31 may be a biomarker for diabetic nephropathy in 
T2DM patients 
[46] 
 Programmed death-ligand 1, targeted in cancer 
immunotherapy, are also expressed in beta cells from T1DM 
patients 
[47] 
Development of a 3D co-culture model of stromal fibroblasts 
and neuronal cells 
[21] 
Cell culture with 
DM patients’ 
serum 
Expression of some splicing machinery was associated with 
risk of developing T2DM in patients with cardiovascular 
disease 
[48] 
Serum interleukin-6 and soluble interleukin-6 receptor in type 






of the disease 
Interleukin-4 boosts insulin-stimulated glucose uptake and 
lipid synthesis in hepatocytes 
[49] 
Poor glycemic control, enhanced platelet activation and 
oxidative stress increase the content of polyhedrocytes in 
blood clots generated in T2D patients 
[50] 
Human umbilical cord-derived mesenchymal stem cells 






Table 2. Summary of advantages and limitations of ​in vitro models           
used in diabetes mellitus research 
Model Advantages Limitations 
In vitro​ (general) 
● Variable control 
● Lower complexity as 
opposed to ​in vivo 
● Allows the measurement of 
reaction kinetics and 
metabolic processes 
● Compliant with 3R 
principles 
● Some cell types 
can’t be cultured 
in vitro 
● High impact of 





● Easy to work 
● Controlled conditions 
● Osmotic shock 
influence  





● Constant glucose 
levels, unlike ​in 
vivo 
 Primary cell cultures derived 
from DM patients  
● Great to study cell 
interaction 
● “Imports” chronic, as well 
as direct and indirect 




● Certain cell lines 








Cell culture with DM patients’ 
serum 
● New discoveries showing 
serum/extracellular 
vesicles importance 
● Brings direct and indirect 
effects of DM to the 
experimental setting 




Strategies focused on isolated 
aspects of the disease 
● Ideal to isolate and study a 
specific metabolic pathway 
● Doesn’t account 
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